Moderna, Merck's Groundbreaking Melanoma Treatment Shows Promise in Combination Therapy Study The collaborative effort harnesses Merck's expertise in immuno-oncology and Moderna's innovative mRNA technology to make a meaningful impact on patient outcomes. by Inno Flores
Health In A First, FDA OKs Cancer Treatment For Tumors With Specific Genetic Feature by Katrina Pascual
Health Merck Clears Clinical Trial Milestone, Shows Promise With Alzheimer’s Drug Verubecestat by Saranya Palanisamy
Health Lung Cancer Treatment: Keytruda Better Than Chemotherapy In Patients With Non-Small Cell Lung Cancer by Rhodi Lee
Healthy Living/Wellness Hundreds Receive Experimental Merck Ebola Vaccine To Fight Flare-Up In Guinea by Rhodi Lee
Healthy Living/Wellness Federal Jury Orders Gilead To Pay Merck $200 Million In Hepa C Drug Patent Dispute by Catherine Cabral-Isabedra
Healthy Living/Wellness Jury Favors Merck Over Gilead In Hepatitis C Drug Patent Dispute by Rhodi Lee
Healthy Living/Wellness Immunotherapy Drug Keytruda More Effective Than Chemotheraphy For Advanced Lung Cancer by Rina Marie Doctor
Healthy Living/Wellness FDA Gives Approval To Bridion, A Surgery Drug That Reverses The Effects Of Muscle Relaxants by Alyssa Navarro
Healthy Living/Wellness Merck's Star Drug Keytruda Improves Overall Survival Of Lung Cancer Patients by Angela Laguipo
Healthy Living/Wellness Studies Say Merck Antibody Cuts Risks Of Clostridium Difficile Recurrence by Dianne Depra
Healthy Living/Wellness Gene Mutation can Lower Heart Attack Risk and Merck's Zetia can Trigger It by Dianne Depra
Healthy Living/Wellness Merck’s new cancer fighter gets FDA approval, is novel 'game changer' by Jim Algar
Healthy Living/Wellness Endocyte Inc. to break into the big leagues with ovarian cancer drug Vynfinit; stock soars by Tabitha Laffernis
Business Tech Merck settles NuvaRing contraceptive lawsuits for $100 mn: What you should know by Anu Passary